Characteristics, phenotypes, mechanisms and management of severe asthma.
Chung KF, Dixey P, Abubakar-Waziri H, Bhavsar P, Patel PH, Guo S, Ji Y.
Chin Med J (Engl). 2022 May 20;135(10):1141-1155. doi: 10.1097/CM9.0000000000001990.
Japanese guidelines for adult asthma 2020.
Nakamura Y, Tamaoki J, Nagase H, Yamaguchi M, Horiguchi T, Hozawa S, Ichinose M, Iwanaga T, Kondo R, Nagata M, Yokoyama A, Tohda Y; Japanese Society of Allergology.
Allergol Int. 2020 Oct;69(4):519-548. doi: 10.1016/j.alit.2020.08.001. Epub 2020 Sep 4.
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].
Chinese Thoracic Society, Chinese Medical Association.
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
Asthma.
Lemanske RF Jr, Busse WW.
JAMA. 1997 Dec 10;278(22):1855-73.
The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma.
Nakagome K, Nagata M.
Biomolecules. 2024 May 2;14(5):546. doi: 10.3390/biom14050546.
Bronchial thermoplasty for severe asthma: potential mechanisms and response markers.
ChunXiao L, Xin H, Yun L, BoWen L, KunLu S, JiangTao L.
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241266348. doi: 10.1177/17534666241266348.
Bronchial thermoplasty for severe asthma.
Thomson NC, Bicknell S, Chaudhuri R.
Curr Opin Allergy Clin Immunol. 2012 Jun;12(3):241-8. doi: 10.1097/ACI.0b013e32835335ca.
[Biologicals in the Treatment of Bronchial Asthma].
Haasler I, Taube C.
Pneumologie. 2017 Oct;71(10):684-698. doi: 10.1055/s-0043-102773. Epub 2017 Oct 10.
[Severe asthma].
Chanez P, Wenzel S.
Presse Med. 2008 Jan;37(1 Pt 2):99-105. doi: 10.1016/j.lpm.2007.05.032. Epub 2007 Dec 4.
Can probiotics be used in the prevention and treatment of bronchial asthma?
Kleniewska P, Pawliczak R.
Pharmacol Rep. 2024 Aug;76(4):740-753. doi: 10.1007/s43440-024-00618-0. Epub 2024 Jul 1.
